January, 05 2021, 11:00pm EDT
Why Progressives Should Care About the Commerce Secretary & Reject Raimondo
WASHINGTON
As President-elect Joe Biden fills out his Cabinet, progressives have pushed hard on most major positions, save one: Commerce Secretary. Recent reporting on the role frames the Commerce Secretary as a glorified middle-man between C-Suites and the White House.
In fact, the work of the Commerce Department impacts all Americans. Yet for decades, Commerce Secretaries have been chosen not for their policy agenda or experience, but as a reward for their massive campaign contributions and personal loyalty to the President. This practice of selling the Commerce Secretary position to the highest bidder has made it difficult to understand just how valuable a populist Commerce Secretary could be.
The benefits of what a progressive Commerce Secretary could mean to American families is what makes Axios' reporting that Rhode Island Governor and corporate insider Gina Raimondo is a frontrunner for the position so troubling. Raimondo, a former venture capitalist, is the wrong pick - and the American public agrees. According to November polling, nearly 70% of respondents oppose President-elect Biden appointing Raimondo to any cabinet position.
Biden's choice of Commerce Secretary will impact several major policy areas: fighting against climate change, pushing back on Republican gerrymandering, and preventing Big Tech from having unchecked government power. Biden must select a Commerce Secretary dedicated to fighting for progressive values and serving as an advocate for the people over big corporations.
Why Progressives Should Care About The Commerce Secretary:
- The Commerce Department houses the U.S. Patent and Trademark Office (USPTO). USPTO has an opportunity to use the patent system to limit Big Pharma's patent monopolies and decrease prescription drug costs. Despite Republicans like Thom Tillis stripping away the USPTO's power to withhold patents on lifesaving drugs, the Department retains enough power that the Biden-Harris Administration can and should act to increase the accessibility of generic drugs.
- The Commerce Secretary would also be charged with running the National Oceanic Atmospheric Administration (NOAA), which plays an important role in combating climate change. NOAA's research and reporting on climate change, including the National Climate Assessment and the annual Arctic Report Card, are essential tools in tracking and publicizing the impact of climate change. NOAA is also responsible for the U.S. Global Change Research Program, which produces the country's definitive report on climate change, the National Climate Assessment. With a strong Commerce Secretary, the Biden-Harris Administration could use the agency to fulfill their promise of centralizing the fight against climate change.
- The Census Bureau, which is also housed in the Commerce Department, has the potential to radically transform the American electorate. Census results are used for redistricting, meaning if Biden's Commerce Secretary is unwilling or unable to fight political interference in the 2020 Census, it could hand Republicans a big win in their attempt to undercount and disenfranchise communities of color. Biden's Commerce Secretary can take several steps to fix the broken 2020 Census process, including directing the Bureau to review the data and increasing overall resources for the Bureau. The 2020 Census is a looming fight that the Biden Administration will need to take on, and a strong and committed Commerce Secretary will be necessary to protect the count.
- The Commerce Department also oversees the International Trade Administration, giving the next Commerce Secretary a significant role in shaping our trade policy. Under Section 232 of the Trade Expansion Act of 1962, the ITA can conduct investigations on the impact of imports on national security, and recommend the use of tariffs or quotas based on the result of these investigations. The International Trade Administration also has the power to blacklist foreign companies from trade with the United States. Having a Commerce Secretary who will evaluate imports based on their impact on working families will be an essential step towards building a progressive trade policy.
Raimondo's disqualifying history of prioritizing Wall Street, lobbyists, and the health insurance industry above the public interest:
- Raimondo has a long history of prioritizing the needs of Wall Street above those of working Rhode Islanders - and helping the wealthy donors who boost her campaigns. "[Raimondo's] so-called 'pension reform' slashed school teachers and other state workers pension benefits by 3%, but increased fees paid to Gina and her Wall Street pals by 2.5% and 4% respectively." - Leading forensic auditor and former SEC attorney, Edward Siedle wrote in Forbes
- At the behest of lobbyists, she issued executive orders to shield nursing homes, hospitals, and other healthcare providers from liability. Documents show that Raimondo quickly responded to lobbyists' demands for an executive order granting them legal immunity during the pandemic, the culmination of a decade-old effort by the Koch-funded American Legislative Exchange Council (ALEC). "What immunity has done is allow nursing homes to act unreasonably without accountability," said Anthony Leone, a Warwick-based personal injury lawyer who specializes in nursing homes." - The Providence Journal
- She approved steep health insurance rate hikes in the midst of the pandemic so health insurance companies could profit. "Some of the rate increases are nearly 10%, all at a time when health insurance companies have been piling up revenues with consumers using fewer services due to the pandemic" - Go Local Providence News
- In the name of a balanced budget, Raimdondo tried to strip Rhode Island's lowest-income areas of 50 percent of a key aid fund mid-pandemic. "Rhode Island's cities and towns are disputing the legality of a 50% cut by the Raimondo administration in a $12.4-million aid program for 'distressed' communities, including 'some with the highest COVID-19 case rates in the state.' The administration put city and town leaders on notice that it was likely to go ahead with the cut that Gov. Gina Raimondo proposed to lawmakers in January." --Providence Journal
- Just this year, she sought to cut $58.7 million from Medicaid, while giving $15.7 million to insurance companies. "When we're pushing brutal Medicaid cuts, we just can't afford to give extra money to insurance companies - especially not when it comes with an initiative to encourage them to cut spending on actual care." - Rhode Island State Senator Samuel Bell in Uprise RI
The Revolving Door Project (RDP) scrutinizes executive branch appointees to ensure they use their office to serve the broad public interest, rather than to entrench corporate power or seek personal advancement.
LATEST NEWS
Senate Tosses 'Dangerous Provision' Preventing State-Level AI Regulation From GOP Megabill
"From the start, this provision had Big Tech's money and lobbyists all over it. This is a major victory for the American people over the AI industry," said one advocate.
Jul 01, 2025
With a 99-1 vote early Tuesday, the Republican-controlled Senate decided to remove a controversial provision that would have prevented state-level regulation on artificial intelligence for 10 years from U.S. President Donald Trump's massive tax and spending bill that is currently being debated in Congress.
Sen. Thom Tillis (R-N.C.) was the lone lawmaker who voted to keep the moratorium in the bill.
While far from the only controversial part of the reconciliation package, the provision drew opposition from an ideologically diverse group that included Democratic and Republican state attorneys general; over 140 groups working to support children's online safety, consumer protections, and responsible innovation; and faith leaders.
Senators struck Sen. Ted Cruz's (R-Texas) AI measure from the megabill by adopting an amendment introduced by Sen. Marsha Blackburn (R-Tenn.). They voted on Blackburn's amendment during a session known as a vote-a-rama. Blackburn introduced the amendment after considering an agreement that would have watered down the provision.
According to The Verge, the measure that was rejected on Tuesday required states to avoid regulation AI and "automated decision systems" if they wanted to get funding for their broadband programs.
The provision would have been a major win for Big Tech, which has made the case that state laws around AI are obstructing their ability to do business.
Advocates and Democratic lawmakers cheered the decision to strip the provision.
"From the start, this provision had Big Tech's money and lobbyists all over it. This is a major victory for the American people over the AI industry. It shows that Americans are aware of the proliferation of AI harms in real time," said J.B. Branch, Big Tech accountability advocate at the watchdog group Public Citizen.
Sen. Edward Markey (D-Mass.) said Tuesday that "early this morning, the Senate overwhelmingly voted to reject a dangerous provision to block states from regulating artificial intelligence, including protecting kids online. This 99-1 vote sent a clear message that Congress will not sell out our kids and local communities in order to pad the pockets of Big Tech billionaires."
In addition to concerns focused on Big Tech, experts recently told The Guardian that in the absence of state-level AI regulation, untrammeled growth of AI would take a toll on the world's "dangerously overheating climate."
Sacha Haworth, the executive director of the Tech Oversight Project, credited the "massive" defeat of Cruz's provision to the "incredible mobilizing by advocates to beat back Big Tech lobbying and last-minute bullying."
Keep ReadingShow Less
Critics Shred JD Vance as He Shrugs Off Millions of Americans Losing Medicaid as 'Minutiae'
"What happened to you J.D. Vance—author of Hillbilly Elegy—now shrugging off Medicaid cuts that will close rural hospitals and kick millions off healthcare as 'minutiae?'" asked Rep. Ro Khanna (D-Calif.).
Jul 01, 2025
Vice President J.D. Vance took heat from critics this week when he downplayed legislation that would result in millions of Americans losing Medicaid coverage as mere "minutiae."
Writing on X, Vance defended the budget megabill that's currently being pushed through the United States Senate by arguing that it will massively increase funding to Immigration and Customs Enforcement, which he deemed to be a necessary component of carrying out the Trump administration's mass deportation operation.
"The thing that will bankrupt this country more than any other policy is flooding the country with illegal immigration and then giving those migrants generous benefits," wrote Vance. "The [One Big Beautiful Bill] fixes this problem. And therefore it must pass."
He then added that "everything else—the CBO score, the proper baseline, the minutiae of the Medicaid policy—is immaterial compared to the ICE money and immigration enforcement provisions."
It was this line that drew the ire of many critics, as the Congressional Budget Office has estimated that the Senate version of the budget bill would slash spending on Medicaid and the Children's Health Insurance Program by more than $1 trillion over a ten-year-period, which would result in more than 10 million people losing their coverage. Additionally, Sen. Rick Scott (R-Fla.) has proposed an amendment that would roll back the expansion of Medicaid under the 2010 Affordable Care Act, which would likely kick millions more off of the program.
Many congressional Democrats were quick to pounce on Vance for what they said were callous comments about a vital government program.
"So if the only thing that matters is immigration... why didn't you support the bipartisan Lankford-Murphy bill that tackled immigration far better than your Ugly Bill?" asked Rep. Daniel Goldman (D-N.Y.). "And it didn't have 'minutiae' that will kick 12m+ Americans off healthcare or raise the debt by $4tn."
"What happened to you J.D. Vance—author of Hillbilly Elegy—now shrugging off Medicaid cuts that will close rural hospitals and kick millions off healthcare as 'minutiae?'" asked Rep. Ro Khanna (D-Calif.).
Veteran healthcare reporter Jonathan Cohn put some numbers behind the policies that are being minimized by the vice president.
"11.8M projected to lose health insurance," he wrote. "Clinics and hospitals taking a hit, especially in rural areas. Low-income seniors facing higher costs. 'Minutiae.'"
Activist Leah Greenberg, the co-chair of progressive organizing group Indivisible, zeroed in on Vance's emphasis on ramping up ICE's funding as particularly problematic.
"They are just coming right out and saying they want an exponential increase in $$$ so they can build their own personal Gestapo," she warned.
Washington Post global affairs columnist Ishaan Tharoor also found himself disturbed by the sheer size of the funding increase for ICE that Vance is demanding and he observed that "nothing matters more apparently than giving ICE a bigger budget than the militaries of virtually every European country."
Keep ReadingShow Less
'Heinrich Should Be Ashamed': Lone Senate Dem Helps GOP Deliver Big Pharma Win
The provision, part of the Senate budget bill, was described as "a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars."
Jul 01, 2025
The deep-pocketed and powerful pharmaceutical industry notched a significant victory on Monday when the Senate parliamentarian ruled that a bill described by critics as a handout to drug corporations can be included in the Republican reconciliation package, which could become law as soon as this week.
The legislation, titled the Optimizing Research Progress Hope and New (ORPHAN) Cures Act, would exempt drugs that treat more than one rare disease from Medicare's drug-price negotiation program, allowing pharmaceutical companies to charge exorbitant prices for life-saving medications in a purported effort to encourage innovation. (Medications developed to treat rare diseases are known as "orphan drugs.")
The consumer advocacy group Public Citizen observed that if the legislation were already in effect, Medicare "would have been barred from negotiating lower prices for important treatments like cancer drugs Imbruvica, Calquence, and Pomalyst."
Among the bill's leading supporters is Sen. Martin Heinrich (D-N.M.), whose spokesperson announced the parliamentarian's decision to allow the measure in the reconciliation package after previously advising that it be excluded. Heinrich is listed as the legislation's only co-sponsor in the Senate, alongside lead sponsor Sen. John Barrasso (R-Wyo.).
"Sen. Heinrich should be ashamed of prioritizing drug corporation profits over lower medicine prices for seniors and people with disabilities," Steve Knievel, access to medicines advocate at Public Citizen, said in a statement Monday. "Patients and consumers breathed a sigh of relief when the Senate parliamentarian stripped the proposal from Republicans' Big Ugly Betrayal, so it comes as a gut punch to hear that Sen. Heinrich welcomed the reversal and continued to champion a proposal that will transfer billions from taxpayers to Big Pharma."
"People across the country are demanding lower drug prices and for Medicare drug price negotiations to be expanded, not restricted," Knievel added. "Sen. Heinrich should apologize to his constituents and start listening to them instead of drug corporation lobbyists."
The Biotechnology Innovation Organization, a lobbying group whose members include pharmaceutical companies, has publicly endorsed and promoted the legislation, urging lawmakers to pass it "as soon as possible."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients."
The nonpartisan Congressional Budget Office has estimated that the ORPHAN Cures Act would cost U.S. taxpayers around $5 billion over the next decade.
Merith Basey, executive director of Patients For Affordable Drugs Now, said that "patients are infuriated to see the Senate cave to Big Pharma by reviving the ORPHAN Cures Act at the eleventh hour."
"This is a blatant giveaway to the pharmaceutical industry that would keep drug prices high for patients while draining $5 billion in taxpayer dollars," said Basey. "We call on lawmakers to remove this unnecessary provision immediately and stand with an overwhelming majority of Americans who want the Medicare Negotiation program to go further. Medicare negotiation will deliver huge savings for seniors and taxpayers; this bill would undermine that progress."
Keep ReadingShow Less
Most Popular